Chebath; Judith

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chebath; Judith.The latest application filed is for "directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)".

Company Profile

4.14.18

Chebath; Judith - Rechovot IL
Chebath; Judith - Rehovot IL
- Rehovot IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS Grant 11,406,670 - Revel , et al. August 9, 2	2022-08-09
Directed Differentiation Of Astrocytes From Human Pluripotent Stem Cells For Use In Drug Screening And The Treatment Of Amyotrophic Lateral Sclerosis (als) App 20210054334 - Izrael; Michal ; et al.	2021-02-25
Method Of Identifying Agents That Affect Maturation, Survival And Myelination App 20200003757 - Revel; Michel ; et al.	2020-01-02
Methods Of Generating Glial And Neuronal Cells And Use Of Same For The Treatment Of Medical Conditions Of The Cns App 20190175658 - Revel; Michel ; et al.	2019-06-13
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS Grant 10,258,651 - Revel , et al.	2019-04-16
Directed Differentiation Of Astrocytes From Human Pluripotent Stem Cells For Use In Drug Screening And The Treatment Of Amyotrophic Laterial Sclerosis (als) App 20180230427 - Izrael; Michal ; et al.	2018-08-16
Methods Of Generating Glial And Neuronal Cells And Use Of Same For The Treatment Of Medical Conditions Of The Cns App 20170362570 - Revel; Michel ; et al.	2017-12-21
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS Grant 9,631,175 - Revel , et al. April 25, 2	2017-04-25
Methods Of Inducing Myelination And Maturation Of Oligodendrocytes App 20170095512 - Izrael; Michal ; et al.	2017-04-06
Directed Differentiation Of Astrocytes From Human Pluripotent Stem Cells For Use In Drug Screening And The Treatment Of Amyotrophic Laterial Sclerosis (als) App 20160237404 - IZRAEL; Michal ; et al.	2016-08-18
Insulin producing cells derived from pluripotent stem cells Grant 9,404,087 - Revel , et al. August 2, 2	2016-08-02
Methods Of Generating Glial And Neuronal Cells And Use Of Same For The Treatment Of Medical Conditions Of The Cns App 20140322179 - Revel; Michel ; et al.	2014-10-30
Method Of Identifying Agents That Affect Maturation, Survival And Myelination App 20140296107 - Revel; Michel ; et al.	2014-10-02
Methods of generating mature oligodendrocytes Grant 8,809,052 - Revel , et al. August 19, 2	2014-08-19
Method of generating oligodendrocytes from neurosphere cells Grant 8,617,887 - Revel , et al. December 31, 2	2013-12-31
Method of generating oligodendrocytes from neurosphere cells Grant 08617887 -	2013-12-31
Insulin Producing Cells Derived From Pluripotent Stem Cells App 20130273013 - Revel; Michel ; et al.	2013-10-17
IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy Grant 8,394,367 - Revel , et al. March 12, 2	2013-03-12
IL6R/IL6 Chimera for Therapy of Chemotherapy-Induced Peripheral Neuropathy App 20110274647 - Revel; Michel ; et al.	2011-11-10
Use of il6r/il6 chimera in nerve cell regeneration Grant 7,824,670 - Haggiag , et al. November 2, 2	2010-11-02
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns App 20100003751 - Revel; Michel ; et al.	2010-01-07
Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof Grant 7,374,912 - Revel , et al. May 20, 2	2008-05-20
Enhancement of oligodendrocyte differrentiation App 20070237748 - Revel; Michel ; et al.	2007-10-11
Chimeric Interleukin-6 Soluble Receptor/Ligand Protein, Analogs Thereof and Uses Thereof App 20070172455 - Revel; Michel ; et al.	2007-07-26
IL6RIL6 chimera for the treatment of neurodegenerative diseases Grant 7,201,896 - Revel , et al. April 10, 2	2007-04-10
Chimeric interleukin-6 soluble receptor/ligand proteins Grant 7,198,781 - Revel , et al. April 3, 2	2007-04-03
Use of il6r/il6 chimera in nerve cell regeneration App 20050220761 - Haggiag, Shalom ; et al.	2005-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.